Specifies a procedure to identify the hazards and hazardous situations and to manage the risk
associated with viable cellular component(s) of products regulated as medicinal products, biologics,
medical devices and active implantable medical devices or combinations thereof. Covers viable
human materials of autologous as well as allogeneic human origin.